top of page
What if we could treat the root cause of disease rather than just the symptoms?
A new generation of therapies is pioneering a paradigm shift in medicine to provide curative outcomes for patients.
One problem is that these next-gen therapies have complex formulation and delivery processes that are challenging to scale.
Large incumbents are leaning on outdated tech rather than innovating, and biopharma and academic medical centers are stuck with inefficient, cumbersome processes.
We’re building a novel platform for drug formulation and dose preparation that leverages recent advances in microfluidics manufacturing, robotics, and AI.
Our mission is to accelerate medicine's transition to curative therapies, and ensure all patients have access to them.
bottom of page